These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38367280)

  • 1. High Target Homology Does Not Guarantee Inhibition: Aminothiazoles Emerge as Inhibitors of
    Johannsen S; Gierse RM; Krüger A; Edwards RL; Nanna V; Fontana A; Zhu D; Masini T; de Carvalho LP; Poizat M; Kieftenbelt B; Hodge DM; Alvarez S; Bunt D; Lacour A; Shams A; Meissner KA; de Souza EE; Dröge M; van Vliet B; den Hartog J; Hutter MC; Held J; Odom John AR; Wrenger C; Hirsch AKH
    ACS Infect Dis; 2024 Mar; 10(3):1000-1022. PubMed ID: 38367280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
    Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
    Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
    Biot C; Dessolin J; Grellier P; Davioud-Charvet E
    Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors.
    Murillo-Solano C; Dong C; Sanchez CG; Pizarro JC
    Malar J; 2017 Jul; 16(1):292. PubMed ID: 28724415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum.
    Le Bras J; Durand R
    Fundam Clin Pharmacol; 2003 Apr; 17(2):147-53. PubMed ID: 12667224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
    Sashidhara KV; Avula SR; Palnati GR; Singh SV; Srivastava K; Puri SK; Saxena JK
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5455-9. PubMed ID: 22850213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria.
    Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U
    Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation.
    Sindhe KMV; Wu W; Legac J; Zhang YK; Easom EE; Cooper RA; Plattner JJ; Freund YR; DeRisi JL; Rosenthal PJ
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
    Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The methylerythritol phosphate pathway is functionally active in all intraerythrocytic stages of Plasmodium falciparum.
    Cassera MB; Gozzo FC; D'Alexandri FL; Merino EF; del Portillo HA; Peres VJ; Almeida IC; Eberlin MN; Wunderlich G; Wiesner J; Jomaa H; Kimura EA; Katzin AM
    J Biol Chem; 2004 Dec; 279(50):51749-59. PubMed ID: 15452112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protein aggregation inhibitor YAT2150 has potent antimalarial activity in Plasmodium falciparum in vitro cultures.
    Bouzón-Arnáiz I; Avalos-Padilla Y; Biosca A; Caño-Prades O; Román-Álamo L; Valle J; Andreu D; Moita D; Prudêncio M; Arce EM; Muñoz-Torrero D; Fernàndez-Busquets X
    BMC Biol; 2022 Oct; 20(1):197. PubMed ID: 36271358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates.
    Chirawurah JD; Ansah F; Nyarko PB; Duodu S; Aniweh Y; Awandare GA
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):399-406. PubMed ID: 29128848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEPicides: α,β-unsaturated Fosmidomycin
    Wang X; Edwards RL; Ball HS; Heidel KM; Brothers RC; Johnson C; Haymond A; Girma M; Dailey A; Roma JS; Boshoff HI; Osbourn DM; Meyers MJ; Couch RD; Odom John AR; Dowd CS
    ACS Infect Dis; 2023 Jul; 9(7):1387-1395. PubMed ID: 37310810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplasmodial dihetarylthioethers target the coenzyme A synthesis pathway in Plasmodium falciparum erythrocytic stages.
    Weidner T; Lucantoni L; Nasereddin A; Preu L; Jones PG; Dzikowski R; Avery VM; Kunick C
    Malar J; 2017 May; 16(1):192. PubMed ID: 28502250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial aminothiazoles and aminopyridines from phenotypic whole-cell screening of a SoftFocus(®) library.
    Paquet T; Gordon R; Waterson D; Witty MJ; Chibale K
    Future Med Chem; 2012 Dec; 4(18):2265-77. PubMed ID: 23234550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border.
    Barends M; Jaidee A; Khaohirun N; Singhasivanon P; Nosten F
    Malar J; 2007 Jun; 6():81. PubMed ID: 17597537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
    Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
    ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
    Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary LC-MS Based Screening for Inhibitors of Plasmodium falciparum Thioredoxin Reductase (PfTrxR) among a Set of Antimalarials from the Malaria Box.
    Tiwari NK; Reynolds PJ; Calderón AI
    Molecules; 2016 Mar; 21(4):424. PubMed ID: 27043496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.